Epoprostenol Levels and Effects while Breastfeeding
Summary of Use during Lactation
No information is available on the use of epoprostenol during breastfeeding. The half-life of epoprostenol is 6 minutes or less. It is unlikely that clinically important amounts of epoprostenol are excreted into milk and absorbed by the breastfed infant.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Substance Identification
Substance Name
Epoprostenol
CAS Registry Number
35121-78-9
Drug Class
Breast Feeding
Lactation
Milk, Human
Cardiovascular Agents
Prostaglandins, Synthetic
Vasodilator Agents
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
